Forte Biosciences holder reports 2.4% stake

Forte Biosciences, Inc. received an updated ownership report from investor Steven Michael Oliveira and Nemean Asset Management, LLC.

Rhea-AI Filing Summary

Forte Biosciences, Inc. received an updated ownership report from investor Steven Michael Oliveira and Nemean Asset Management, LLC. Together they report beneficial ownership of 300,100 shares of Forte Biosciences common stock, representing 2.4% of the outstanding class as of the event date of 01/08/2026. Voting and disposition power over these shares is reported as shared rather than sole.

The filers certify that the securities were not acquired and are not held for the purpose of changing or influencing control of Forte Biosciences, and that they are not participating in any control-related transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Forte Biosciences (FBRX) shares do Steven Oliveira and Nemean Asset Management report owning?

They report beneficial ownership of 300,100 shares of Forte Biosciences common stock.

What percentage of Forte Biosciences (FBRX) does 300,100 shares represent?

The filing states that 300,100 shares represent 2.4% of Forte Biosciences' outstanding common stock.

Who are the reporting persons in this Forte Biosciences (FBRX) ownership filing?

The reporting persons are Steven Michael Oliveira and Nemean Asset Management, LLC.

Do the reporting persons claim control over Forte Biosciences (FBRX)?

No. They certify the shares were not acquired and are not held to change or influence control of Forte Biosciences.

What type of power do the filers have over the Forte Biosciences (FBRX) shares?

They report shared voting power and shared dispositive power over 300,100 shares of common stock.

What is the date of the event that triggered this Forte Biosciences (FBRX) ownership report?

The date of the event requiring the filing is listed as 01/08/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/09/2026 - 06:19 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Forte Biosciences, Inc.

(Name of Issuer)

Common Stock, $0.001 par value

(Title of Class of Securities)

34962G208

(CUSIP Number)

01/08/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 34962G208

1

Names of Reporting Persons

Oliveira Steven Michael

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 300,100.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 300,100.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

300,100.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.4 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

CUSIP No. 34962G208

1

Names of Reporting Persons

Nemean Asset Management, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

FLORIDA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 300,100.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 300,100.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

300,100.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

2.4 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Forte Biosciences, Inc.
(b)	Address of issuer's principal executive offices: 3060 PEGASUS PARK DRIVE, BUILDING 6, DALLAS, TEXAS 75247
Item 2.
(a)	Name of person filing: Steven Michael Oliveira Neaman Asset Management, LLC
(b)	Address or principal business office or, if none, residence: Steven Oliveira: c/o Nemean Asset Management, LLC 207 Commodore Drive Jupiter, FL 33477 Nemean Asset Management, LLC: 207 Commodore Drive Jupiter, FL 33477
(c)	Citizenship: US, FL
(d)	Title of class of securities: Common Stock, $0.001 par value
(e)	CUSIP No.: 34962G208
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 300,100
(b)	Percent of class: 2.4 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Steven Oliveira - 0 Neaman Asset Management, LLC - 0
	(ii) Shared power to vote or to direct the vote: Steven Oliveira - 161,218 Neaman Asset Management, LLC - 300,100
	(iii) Sole power to dispose or to direct the disposition of: Steven Oliveira - 0 Neaman Asset Management, LLC - 0
	(iv) Shared power to dispose or to direct the disposition of: Steven Oliveira - 161,218 Neaman Asset Management, LLC - 300,100
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Oliveira Steven Michael

Signature:	/s/ Oliveira Steven Michael
Name/Title:	Individual
Date:	01/09/2026

Nemean Asset Management, LLC

Signature:	/s/ Oliveira Steven Michael
Name/Title:	Authorized Signer
Date:	01/09/2026